Clinical Characteristics and Prognostic Clinical Factors of Anti-Gamma Acid-B Receptor (Gabab-R) Encephalitis in Türkiye: a Multicenter Study
dc.authorscopusid | 55826416500 | |
dc.authorscopusid | 6602570293 | |
dc.authorscopusid | 57063446900 | |
dc.authorscopusid | 7004137692 | |
dc.authorscopusid | 6602078414 | |
dc.authorscopusid | 37666211300 | |
dc.authorscopusid | 59772265600 | |
dc.authorwosid | Ertürk Çetin, Özdem/Hhs-8773-2022 | |
dc.authorwosid | Yilmaz, Vuslat/Aab-9205-2020 | |
dc.authorwosid | Gozubatik-Celik, Rabia Gokcen/Adz-4733-2022 | |
dc.authorwosid | Kurtuncu, Murat/L-2705-2015 | |
dc.authorwosid | Uzunköprü, Cihat/W-4303-2017 | |
dc.authorwosid | Tuzun, Erdem/Aah-9212-2019 | |
dc.authorwosid | Şanlı, Elif/Aag-5575-2019 | |
dc.contributor.author | Gozubatik-Celik, Rabia Gokcen | |
dc.contributor.author | Baykan, Betul | |
dc.contributor.author | Emekli, Ahmed Serkan | |
dc.contributor.author | Tuzun, Erdem | |
dc.contributor.author | Soysal, Aysun | |
dc.contributor.author | Uzunkopru, Cihat | |
dc.contributor.author | Terzi, Murat | |
dc.date.accessioned | 2025-06-01T20:05:31Z | |
dc.date.available | 2025-06-01T20:05:31Z | |
dc.date.issued | 2025 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Gozubatik-Celik, Rabia Gokcen; Soysal, Aysun] Univ Hlth Sci, Bakirkoy Prof Dr Mazhar Osman Training & Res Hosp, Dept Neurol, TR-34147 Istanbul, Turkiye; [Baykan, Betul] EMAR Med Ctr, Dept Neurol, Istanbul, Turkiye; [Emekli, Ahmed Serkan; Hanagasi, Hasmet; Kurtuncu, Murat] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkiye; [Tuzun, Erdem; Sanli, Elif; Yilmaz, Vuslat] Istanbul Univ, Dept Neurosci, Aziz Sancar Inst Expt Med DETAE, Istanbul, Turkiye; [Uzunkopru, Cihat] Izmir Katip Celebi Univ, Fac Med, Dept Neurol, Izmir, Turkiye; [Ilhan Algin, Demet] Eskisehir Osmangazi Univ, Fac Med, Dept Neurol, Eskisehir, Turkiye; [Comruk, Erol] Malatya Training & Res Hosp, Dept Neurol, Malatya, Turkiye; [Akkoyun Arikan, Fatma] Kutahya Univ Hlth Sci, Dept Neurol, Kutahya, Turkiye; [Erturk Cetin, Ozdem] Univ Hlth Sci, Sancaktepe Sehit Prof Dr Ilhan Varank Training & R, Istanbul, Turkiye; [Velioglu, Sibel] Karadeniz Tech Univ, Fac Med, Dept Neurol, Trabzon, Turkiye; [Cerrahoglu Sirin, Tuba; Yalaz Tekan, Ulgen] Sisli Hamidiye Etfal Training & Res Hosp, Dept Neurol, Istanbul, Turkiye; [Yayla, Vildan] Univ Hlth Sci, Sadi Konuk Training & Res Hosp, Dept Neurol, Istanbul, Turkiye; [Cilingir, Vedat] Van Yuzuncu Yil Univ, Fac Med, Dept Neurol, Van, Turkiye; [Basturk Ayhan, Zeliha] Balikesir Ataturk City Hosp, Dept Neurol, Balikesir, Turkiye; [Terzi, Murat] Ondokuz Mayis Univ, Fac Med, Dept Neurol, Samsun, Turkiye | en_US |
dc.description.abstract | Introduction: GABAB-R encephalitis is a rare recognized autoimmune disease. This study investigates the clinical and laboratory features, treatment response, prognosis, and malignancy associations in GABAB-R encephalitis. Methods: We included consecutive encephalitis patients with GABAB-R autoantibodies and retrospectively analyzed their clinical data, neuroimaging, EEG findings, seizure characteristics, treatment responses, prognosis, and cancer presence. Prognosis was classified using the final Modified Rankin Score (mRS), with mRS > 2 indicating poor prognosis. Results: There were 17 patients with GABAB-R antibodies (12 males). The mean age at onset was 61.29 (range: 37-86), and the mean follow-up was 20.3 months (range: 6-60). The most common findings at onset were seizures, observed in 10 patients (58.8%), which increased to 13 patients (76.5%) during follow-up, psychiatric symptoms in 35.3%, and hyponatremia in 35.3%. Ten patients required intensive care unit (ICU) admission, and 11 patients had an underlying malignancy, predominantly lung cancer. Additionally, one patient had CASPR2 antibodies, and another had AMPA-R antibodies. Lesion probability map analysis revealed predominant involvement of the bilateral mesiotemporal regions. Patients with a final modified Rankin Scale Score greater than 2 (n = 10) exhibited a higher prevalence of psychiatric symptoms, ICU admission, and hyponatremia. Of the 12 patients on anti-seizure medications, only 8 achieved seizure-free status during follow-up. Those with a paraneoplastic etiology were more likely to present with psychiatric symptoms. Mortality, which occurred in 7 patients, was associated with persistent seizures (4/4 vs 3/10; p = 0.015) and ICU admission (7/7 vs 3/10 p = 0.010) Patients with both serum and CSF antibody positivity showed trends towards exhibiting higher rates of lung cancer and mortality. Discussion: Male gender and seizures are common in GABAB-R encephalitis, which also displays high malignancy and mortality rates. Remarkable prognostic factors include psychiatric symptoms, seizures, malignancy, and hyponatremia. 4(23%) of 17 patients with GABA-B receptor antibody encephalitis experience persistent seizures during follow-up. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1080/01616412.2025.2495932 | |
dc.identifier.issn | 0161-6412 | |
dc.identifier.issn | 1743-1328 | |
dc.identifier.pmid | 40314255 | |
dc.identifier.scopus | 2-s2.0-105004301849 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.uri | https://doi.org/10.1080/01616412.2025.2495932 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/25023 | |
dc.identifier.wos | WOS:001480627700001 | |
dc.identifier.wosquality | Q4 | |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Autoimmune Encephalitis | en_US |
dc.subject | Anti-Gaba-B Receptor Antibodies | en_US |
dc.subject | Anti-Ampa Receptor Antibodies | en_US |
dc.subject | Caspr2 Antibodies | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Paraneoplastic Syndrome | en_US |
dc.title | Clinical Characteristics and Prognostic Clinical Factors of Anti-Gamma Acid-B Receptor (Gabab-R) Encephalitis in Türkiye: a Multicenter Study | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |